| Antimicrobial peptides: mechanism of action, activity and clinical potential QY Zhang, ZB Yan, YM Meng, XY Hong, G Shao, JJ Ma, XR Cheng, J Liu, ... Military Medical Research 8 (1), 1-25, 2021 | 820 | 2021 |
| The independence of and associations among apoptosis, autophagy, and necrosis Q Chen, J Kang, C Fu Signal transduction and targeted therapy 3 (1), 1-11, 2018 | 386 | 2018 |
| Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy J Kang, N Brajanovski, KT Chan, J Xuan, RB Pearson, E Sanij Signal Transduction and Targeted Therapy 6 (1), 1-22, 2021 | 299 | 2021 |
| Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells J Kang, CM Sergio, RL Sutherland, EA Musgrove BMC cancer 14 (1), 1-13, 2014 | 166 | 2014 |
| Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells CE Caldon, CM Sergio, J Kang, A Muthukaruppan, MN Boersma, A Stone, ... Molecular cancer therapeutics 11 (7), 1488-1499, 2012 | 163 | 2012 |
| Combination therapy targeting ribosome biogenesis and mRNA translation synergistically extends survival in MYC-driven lymphoma JR Devlin, KM Hannan, N Hein, C Cullinane, E Kusnadi, PY Ng, ... Cancer discovery 6 (1), 59-70, 2016 | 135 | 2016 |
| CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer E Sanij, KM Hannan, J Xuan, S Yan, JE Ahern, AS Trigos, N Brajanovski, ... Nature communications 11 (1), 1-18, 2020 | 132 | 2020 |
| Cystathionine β-synthase in physiology and cancer H Zhu, S Blake, KT Chan, RB Pearson, J Kang BioMed research international 2018, 2018 | 124 | 2018 |
| Artemin is oncogenic for human mammary carcinoma cells J Kang, JK Perry, V Pandey, GC Fielder, B Mei, PX Qian, ZS Wu, T Zhu, ... Oncogene 28 (19), 2034-2045, 2009 | 116 | 2009 |
| Regulation of rDNA transcription in response to growth factors, nutrients and energy EP Kusnadi, KM Hannan, RJ Hicks, RD Hannan, RB Pearson, J Kang Gene 556 (1), 27-34, 2015 | 112 | 2015 |
| Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma N Kannan, J Kang, X Kong, J Tang, JK Perry, KM Mohankumar, LD Miller, ... Neoplasia 12 (12), 1041-IN31, 2010 | 101 | 2010 |
| Oncogene-induced senescence: from biology to therapy H Zhu, S Blake, FK Kusuma, RB Pearson, J Kang, KT Chan Mechanisms of ageing and development 187, 111229, 2020 | 90 | 2020 |
| Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload C Ge, H Huang, F Huang, T Yang, T Zhang, H Wu, H Zhou, Q Chen, Y Shi, ... Proceedings of the National Academy of Sciences 116 (39), 19635-19645, 2019 | 73 | 2019 |
| Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells V Pandey, PX Qian, J Kang, JK Perry, MD Mitchell, Z Yin, ZS Wu, DX Liu, ... Endocrinology 151 (3), 909-920, 2010 | 67 | 2010 |
| PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells Y Lu, TF Zhang, Y Shi, HW Zhou, Q Chen, BY Wei, X Wang, TX Yang, ... Scientific reports 6 (1), 1-12, 2016 | 65 | 2016 |
| Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma J Kang, PX Qian, V Pandey, JK Perry, LD Miller, ET Liu, T Zhu, DX Liu, ... Oncogene 29 (22), 3228-3240, 2010 | 65 | 2010 |
| A functional genetic screen defines the AKT-induced senescence signaling network KT Chan, S Blake, H Zhu, J Kang, AS Trigos, PB Madhamshettiwar, ... Cell Death & Differentiation 27 (2), 725-741, 2020 | 60 | 2020 |
| ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma A Banerjee, ZS Wu, PX Qian, J Kang, V Pandey, DX Liu, T Zhu, PE Lobie Breast cancer research 13 (6), 1-20, 2011 | 60 | 2011 |
| Artemin-stimulated progression of human non–small cell lung carcinoma is mediated by BCL2 JZ Tang, XJ Kong, J Kang, GC Fielder, M Steiner, JK Perry, ZS Wu, Z Yin, ... Molecular Cancer Therapeutics 9 (6), 1697-1708, 2010 | 57 | 2010 |
| ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling A Banerjee, ZS Wu, PX Qian, J Kang, DX Liu, T Zhu, PE Lobie PloS one 7 (11), e50098, 2012 | 48 | 2012 |
